Maddy summaryThis bill requires Congress to approve major federal regulations before they take effect. It would mandate that agencies submit detailed reports including cost-benefit analyses, economic impact assessments, and other information to Congress before implementing significant regulations. Major rules - defined as those with at least $100 million annual economic impact or significant effects on costs, competition, or employment - would need a joint resolution of approval from Congress within 70 session days. Nonmajor rules would follow a less stringent disapproval process. The bill aims to increase legislative oversight of the regulatory process, requiring Congress to formally review and approve rules that significantly impact the economy or public regulations.
Rep. Rick W. Allen
Sponsored bills
Maddy summaryThis bill names the U.S. Postal Service facility at 15 South Valdosta Road in Lakeland, Georgia, as the "Nell Patten Roquemore Post Office." It updates all official U.S. government references - such as maps, documents, and records - to use this new name for the location. The bill does not create new policies or affect services; it only changes the facility's official designation. The name honors Nell Patten Roquemore, though the bill itself does not detail her contributions.
Maddy summaryThe FOCA Act of 2023 requires federal agencies to stop mandating or banning contractor agreements with labor organizations (like union contracts) in construction project bids and contracts. It directly affects federal contractors, subcontractors, and agencies managing construction projects funded by the government. The bill prohibits favoring or penalizing contractors based on their labor affiliation status, aiming to promote fair competition and reduce costs. It also mandates updates to federal contracting rules within 60 days of enactment to implement these changes.
Maddy summaryThis bill requires the Inspector General of Health and Human Services to submit quarterly reports to specific congressional committees on Medicare and Medicaid fraud investigations, prosecutions, alleged fraud amounts, charges, and exclusions from federal health programs. It mandates these reports for two years after enactment, with no new funding authorized for this requirement. The bill does not change program rules or allocate funds - it only establishes a reporting mechanism to increase transparency about fraud enforcement.
Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.
Maddy summary# Summary of Proposed Legislation This document outlines a comprehensive U.S. legislative proposal with several key components: 1. **Research Restrictions**: - Requires certification from Federal research grant recipients that they are not Chinese citizens or participants in Chinese talent programs - Prohibits employment of Chinese nationals in federally funded research - Requires institutions receiving Federal assistance to agree not to knowingly employ individuals participating in Chinese talent programs 2. **Foreign Gifts and Contracts Disclosure**: - Mandates disclosure of foreign gifts/contracts over $50,000 to universities - Requires public reporting of restricted/conditional gifts/contracts - Creates a searchable public database of foreign gifts to universities - Requires institutions to maintain policies regarding foreign gifts to faculty and staff 3. **Investment Restrictions**: - Restricts tax-exempt organizations from holding investments in "disqualified Chinese companies" (defined as corporations incorporated in China or with significant Chinese government ownership) - Requires annual reporting on such investments - Allows limited waivers with public disclosure 4. **Taiwan Policy**: - Prohibits U.S. government from recognizing PRC claims to sovereignty over Taiwan without Taiwan's consent - Requires U.S. government to treat Taiwan's democratically elected government as the legitimate representative of the people of Taiwan - Requires a strategy to protect U.S. businesses from Chinese coercion efforts 5. **Additional Provisions**: - Requires participants in Chinese talent programs to register as agents of the Chinese government - Amends economic espionage laws to include education and research - Mandates disclosure of certain funds received by visa holders The legislation represents a significant effort to limit Chinese influence in U.S. academic institutions, research, and business sectors while establishing a more robust policy framework regarding Taiwan.
Maddy summaryThis bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.
Maddy summaryThe Maximum Pressure Act (HR 6114) is a legislative proposal that would maintain and expand U.S. sanctions against Iran. The bill would codify existing sanctions, require Iran to meet 12 specific conditions before sanctions could be lifted (including ending support for terrorism, releasing hostages, and ending nuclear enrichment), and expand sanctions on Iran's Revolutionary Guard Corps and missile programs. It also establishes new reporting requirements for the U.S. government to monitor Iran's activities and the impact of sanctions. The legislation would require congressional review before any sanctions could be lifted or modified, preventing the executive branch from unilaterally easing restrictions.
Maddy summaryThe Maintaining Investments in New Innovation Act (HR 5547) extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines an "advanced drug product" as a drug using genetically targeted technology to change how genes work, such as drugs that suppress or activate gene function. The bill amends the Social Security Act to update the definition of "qualifying single source drug" to include these advanced therapies with the longer exclusivity period. This change directly affects drug manufacturers developing such advanced therapies and influences Medicare's drug coverage rules by delaying generic competition for these specific treatments.
Maddy summaryThis bill modifies the $800 de minimis exemption for small shipments entering the U.S. duty-free. It excludes goods from nonmarket economy countries and nations on the U.S. trade "priority watchlist" from this exemption. Importers must submit detailed documentation (including origin, value, shipper details, and classification) to U.S. Customs within 180 days of enactment. Providing false information could result in $5,000 civil penalties per violation. The changes apply to shipments entered on or after 180 days after the bill’s enactment.